Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.
Co-Founder and acting CEO at Delee Corp. Velarde has been responsible for the development and execution of the company's strategic plans. Velarde's outstanding work has been highly regarded by international institutions such as Cartier Women's Initiative Awards and WeXchange (from the Inter-American Development Bank). She also lead and supervised the development of the Zen FluidicsTM scientific line, a group of products that enables researchers to develop their own microfluidic applications.
